Terns Pharmaceuticals, Inc. Common Stock(TERN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

TERN iron condor setups TERN expected move TERN IV rank history TERN Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

TERN $52.97 —
Snapshot
$52.97
52-Week Range
$5.34 – $53.19
YTD
+32.05%
IV Rank (30D)
0.45
Straddle Price
$8.00
P/C Vol Ratio
3.41
Market Cap
$6.1B
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$6.1B

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of chronic disease. The company's oncology asset is TERN-701, a novel, oral allosteric BCR-ABL1 inhibitor for CML currently in Phase 1/2 development. The company's legacy metabolic programs include TERN-501, a clinical-stage thyroid hormone receptor-Beta for MASH and/or obesity, and TERN-801, a glucose-dependent insulinotropic polypeptide receptor antagonist development candidate for obesity. The compa…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 1995 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $52.78
SMA 50: $49.21
SMA 200: $27.75
Current: $52.95
EMA 12: $52.82
EMA 26: $51.86
MACD: 0.9616 | Signal: -0.3121
BULLISH
ADX (14): 49.31
STRONG TREND
+DI: 29.45
−DI: 8.99
Momentum Oscillators
RSI (14): 73.93
OVERBOUGHT
Stoch %K: 90.09
Stoch %D: 89.28
Williams %R: -8.11
Volume & Volatility
BB Upper: $53.05
BB Lower: $52.51
NEUTRAL
OBV: 187,205,935
Vol SMA 20: 6,318,501
Vol ROC: 52.84%
ATR: $0.43
True Range: $0.05
HV 20: 2.0%
HV 30: 17.6%
HV 60: 31.1%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-05-06T00:00:00 – 2026-05-04T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
7 of 7 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-05 Pre-Market 44.57% 0.54% 0.01x Within
2024-11-12 After-Close 13.25% 5.44% 0.41x Within
2025-03-20 Pre-Market 67.69% 3.38% 0.05x Within
2025-05-08 Pre-Market 35.54% 0.66% 0.02x Within
2025-08-05 Pre-Market 28.26% 5.74% 0.20x Within
2025-11-10 Pre-Market 15.97% 2.38% 0.15x Within
2026-01-09 After-Close 12.41% 3.04% 0.24x Within
Options Activity
IV Rank (30D)
0.45
IV Rank (7D)
8.47
Avg IV
53.7%
Straddle (30D)
$8.00
Straddle (7D)
$0.57
P/C Volume
3.41
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Insufficient price history — listed 1995 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 91,979,271 (as of 2025-12-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

301 filers123,240,724 shares$5.98B value133.99% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 9,569,585 $504.51M 8.44% 10.40% 2026-03-31
2 MORGAN STANLEY Custodian 7,945,608 $321.00M 5.37% 8.64% 2025-12-31
3 Avoro Capital Advisors LLC 5,695,000 $300.24M 5.02% 6.19% 2026-03-31
4 VANGUARD GROUP INC Custodian 5,523,948 $223.17M 3.73% 6.01% 2025-12-31
5 Holocene Advisors, LP 4,115,828 $216.99M 3.63% 4.47% 2026-03-31
6 CITADEL ADVISORS LLC Custodian 3,218,810 $169.70M 2.84% 3.50% 2026-03-31
7 MILLENNIUM MANAGEMENT LLC Custodian 3,011,558 $158.77M 2.66% 3.27% 2026-03-31
8 JPMORGAN CHASE & CO Custodian 2,869,728 $151.75M 2.54% 3.12% 2026-03-31
9 BALYASNY ASSET MANAGEMENT L.P. 2,779,445 $146.53M 2.45% 3.02% 2026-03-31
10 FRANKLIN RESOURCES INC Custodian 2,409,019 $127.00M 2.12% 2.62% 2026-03-31
11 GEODE CAPITAL MANAGEMENT, LLC Custodian 2,316,544 $122.15M 2.04% 2.52% 2026-03-31
12 Paradigm Biocapital Advisors LP 2,216,499 $116.85M 1.95% 2.41% 2026-03-31
13 Nearwater Capital Markets, Ltd 2,150,400 $113.37M 1.90% 2.34% 2026-03-31
14 STATE STREET CORP 2,139,662 $112.80M 1.89% 2.33% 2026-03-31
15 ADAGE CAPITAL PARTNERS GP, L.L.C. 2,124,817 $112.02M 1.87% 2.31% 2026-03-31
16 CAPITOLIS LIQUID GLOBAL MARKETS LLC 1,975,800 $104.16M 1.74% 2.15% 2026-03-31
17 ACORN CAPITAL ADVISORS, LLC 1,746,264 $92.06M 1.54% 1.90% 2026-03-31
18 Pictet Asset Management Holding SA 1,655,575 $87.29M 1.46% 1.80% 2026-03-31
19 Logos Global Management LP 1,500,000 $79.08M 1.32% 1.63% 2026-03-31
20 JANUS HENDERSON GROUP PLC 1,470,057 $77.51M 1.30% 1.60% 2026-03-31
21 Ikarian Capital, LLC 1,456,378 $76.78M 1.28% 1.58% 2026-03-31
22 Capital International Investors 1,424,504 $75.10M 1.26% 1.55% 2026-03-31
23 Vivo Capital, LLC 1,334,418 $70.35M 1.18% 1.45% 2026-03-31
24 DIMENSIONAL FUND ADVISORS LP Custodian 1,247,845 $65.79M 1.10% 1.36% 2026-03-31
25 UBS Group AG Custodian 1,228,726 $64.78M 1.08% 1.34% 2026-03-31
31 filers$423.60M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $59.47M 14.04% 2026-03-31
2 BALYASNY ASSET MANAGEMENT L.P. $58.41M 13.79% 2026-03-31
3 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $53.58M 12.65% 2026-03-31
4 GROUP ONE TRADING LLC Custodian $31.76M 7.50% 2026-03-31
5 LMR Partners LLP $27.01M 6.38% 2026-03-31
6 Logos Global Management LP $26.36M 6.22% 2026-03-31
7 TUDOR INVESTMENT CORP ET AL $23.37M 5.52% 2026-03-31
8 MILLENNIUM MANAGEMENT LLC Custodian $20.13M 4.75% 2026-03-31
9 Sand Grove Capital Management LLP $16.66M 3.93% 2026-03-31
10 JANE STREET GROUP, LLC Custodian $15.29M 3.61% 2026-03-31
11 Fort Baker Capital Management LP $14.48M 3.42% 2026-03-31
12 Hudson Bay Capital Management LP $13.56M 3.20% 2026-03-31
13 ADAR1 Capital Management, LLC $10.54M 2.49% 2026-03-31
14 CITADEL ADVISORS LLC Custodian $10.53M 2.49% 2026-03-31
15 SIMPLEX TRADING, LLC Custodian $6.42M 1.51% 2026-03-31
16 Centiva Capital, LP $5.31M 1.25% 2026-03-31
17 GOLDMAN SACHS GROUP INC Custodian $5.27M 1.24% 2026-03-31
18 Stonepine Capital Management, LLC $5.27M 1.24% 2026-03-31
19 FMR LLC Custodian $4.22M 1.00% 2026-03-31
20 Atika Capital Management LLC $3.80M 0.90% 2026-03-31
21 PEAK6 LLC $2.69M 0.63% 2026-03-31
22 MOORE CAPITAL MANAGEMENT, LP $2.64M 0.62% 2026-03-31
23 Schonfeld Strategic Advisors LLC $2.64M 0.62% 2026-03-31
24 Walleye Trading LLC $1.42M 0.34% 2026-03-31
25 Cannon Global Investment Management, LLC $1.32M 0.31% 2026-03-31
15 filers$256.96M notional
# Filer Notional Value % of Total Period
1 Ikarian Capital, LLC $63.26M 24.62% 2026-03-31
2 Verition Fund Management LLC $39.54M 15.39% 2026-03-31
3 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $31.49M 12.25% 2026-03-31
4 WHITEBOX ADVISORS LLC $26.36M 10.26% 2026-03-31
5 BOOTHBAY FUND MANAGEMENT, LLC $18.45M 7.18% 2026-03-31
6 CITADEL ADVISORS LLC Custodian $17.33M 6.74% 2026-03-31
7 LMR Partners LLP $15.82M 6.16% 2026-03-31
8 WATER ISLAND CAPITAL LLC $9.94M 3.87% 2026-03-31
9 JANE STREET GROUP, LLC Custodian $7.16M 2.79% 2026-03-31
10 EQUITEC PROPRIETARY MARKETS, LLC $6.42M 2.50% 2026-03-31
11 Centiva Capital, LP $5.91M 2.30% 2026-03-31
12 Caption Management, LLC $5.27M 2.05% 2026-03-31
13 TUDOR INVESTMENT CORP ET AL $5.21M 2.03% 2026-03-31
14 GROUP ONE TRADING LLC Custodian $3.38M 1.32% 2026-03-31
15 SIMPLEX TRADING, LLC Custodian $1.42M 0.55% 2026-03-31
Insider Activity
Latest: 2026-05-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-05 Heather D Turner Director Disp (D) −110,697 opt — EDGAR
2026-05-05 JEFFREY B KINDLER Director Disp (D) −208,505 opt — EDGAR
2026-05-05 Jill M. Quigley Director Disp (D) −147,309 opt — EDGAR
2026-05-05 DAVID A FELLOWS Director Disp (D) −221,136 opt — EDGAR
2026-05-05 Amy L. Burroughs Chief Executive Officer Mixed −304,933 $53.00 -$16.16M EDGAR
2026-05-05 Robert Azelby Director Disp (D) −91,697 opt — EDGAR
2026-05-05 Emil Kuriakose Chief Medical Officer Mixed −106,515 $53.00 -$5.65M EDGAR
2026-05-05 Andrew Gengos Chief Financial Officer Mixed −109,253 $53.00 -$5.79M EDGAR
2026-05-05 Radhika Tripuraneni Director Disp (D) −190,030 opt — EDGAR
2026-04-02 Emil Kuriakose Chief Medical Officer Sell (S) −942 $52.75 -$49.7K EDGAR
2026-03-17 Amy L. Burroughs Chief Executive Officer Mixed — $25.67 -$613.4K EDGAR
2026-02-18 Amy L. Burroughs Chief Executive Officer Mixed — $21.92 -$503.9K EDGAR
2026-02-02 Heather D Turner Director Grant (A) +1,697 opt — EDGAR
2026-02-02 Robert Azelby Director Grant (A) +1,697 opt — EDGAR
2026-02-02 Jill M. Quigley Director Grant (A) +1,697 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
17 insiders · @ $52.95
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Deerfield Mgmt L.P. 10%+ Owner 2,382,033 $126.13M $45.22M 1 2021-02-09
2 OrbiMed Asia GP III, L.P. Director 1,973,881 $104.52M $44.65M 1 2022-08-18
3 CARL L GORDON Director 1,968,480 $104.23M $17.44M 9 2024-07-17
4 OrbiMed Advisors III Ltd Director 1,516,481 $80.30M $32.30M 1 2021-02-09
5 OrbiMed Capital GP VII LLC Director 762,400 $40.37M $5.00M 1 2022-12-28
6 ORBIMED ADVISORS LLC Director 755,635 $40.01M -$2.81M 1 2024-07-17
7 LAV Biosciences Fund V, L.P. 10%+ Owner 529,762 $28.05M -$33.00M 2 2022-11-28
8 Hongbo Lu Director 476,190 $25.21M $19.64M 11 2025-06-12
9 Vivo Capital Fund VIII, L.P. 10%+ Owner 281,223 $14.89M $75.28M 2 2022-08-16
10 Vivo Capital VIII, LLC 10%+ Owner 281,223 $14.89M $27.50M 1 2022-12-23
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-01-15
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-01-15 AMY BURROUGHS Director, Officer 97,915 $3.64M 2026-01-15 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-11-04 JILL QUIGLEY Director 24,520 $344.0K 2025-11-04 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-01-06 MARK J VIGNOLA Officer 9,059 $52.1K 2025-01-06 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-01-06 JILL QUIGLEY Director 8,760 $50.4K 2025-01-06 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2024-09-10 SEOKHO BRYAN YOON Officer 10,000 $91.2K 2024-09-10 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2024-09-10 MARK J VIGNOLA Officer 10,000 $91.2K 2024-09-10 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2024-09-09 JILL QUIGLEY Officer 8,857 $69.2K 2024-09-09 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2024-07-15 JILL QUIGLEY Director, Officer 32,000 $297.9K 2024-07-15 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2024-07-15 OrbiMed Asia Partners III, LP Director, Shareholder 131,700 $1.23M 2024-07-15 TD Cowen — EDGAR
2024-07-15 OrbiMed Private Investments VII, LP Director, Shareholder 976,800 $9.09M 2024-07-15 TD Cowen — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio6.1
EV/EBITDA-50.8
TTM Net Income$-0.1B
TTM EPS$-1.03
ROE-9.6%